Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 AUD | +1.38% | -1.68% | +12.69% |
12/04 | RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 | MT |
18/03 | Monash IVF Group Limited(ASX:MVF) added to S&P/ASX Small Ordinaries Index | CI |
Sales 2024 * | 254M 167M 13.93B | Sales 2025 * | 274M 180M 15.01B | Capitalization | 571M 375M 31.27B |
---|---|---|---|---|---|
Net income 2024 * | 27M 17.73M 1.48B | Net income 2025 * | 32M 21.01M 1.75B | EV / Sales 2024 * | 2.41 x |
Net Debt 2024 * | 41.72M 27.4M 2.29B | Net Debt 2025 * | 31.24M 20.51M 1.71B | EV / Sales 2025 * | 2.2 x |
P/E ratio 2024 * |
21
x | P/E ratio 2025 * |
17.5
x | Employees | 867 |
Yield 2024 * |
3.42% | Yield 2025 * |
4.05% | Free-Float | 92.87% |
Latest transcript on Monash IVF Group Limited
1 day | +1.38% | ||
1 week | -1.68% | ||
Current month | +1.38% | ||
1 month | +1.38% | ||
3 months | +3.17% | ||
6 months | +13.57% | ||
Current year | +12.69% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Knaap
CEO | Chief Executive Officer | - | 31/15/31 |
Malik Jainudeen
DFI | Director of Finance/CFO | - | 01/14/01 |
Thierry Panthier
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Broekhuizen
BRD | Director/Board Member | 58 | 04/14/04 |
Richard Davis
CHM | Chairman | 68 | 04/14/04 |
Richard Henshaw
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 1.465 | +1.38% | 350,830 |
26/24/26 | 1.445 | -4.30% | 501,182 |
24/24/24 | 1.51 | -0.33% | 1,157,605 |
23/24/23 | 1.515 | +1.68% | 1,001,317 |
Delayed Quote Australian S.E., April 29, 2024 at 11:40 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.69% | 367M | |
-14.58% | 84.68B | |
+15.05% | 81.12B | |
+10.49% | 29.59B | |
-10.17% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.86% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- MVF Stock